buscar
volver
  CLART® PneumoVir
CE Mark

CLART® PneumoVir provides a multiple diagnosis test of several respiratory viruses through the innovative low density array platform for in vitro diagnosis use.

CLART® PneumoVir ADVANTAGES:

  •  Allows a fast and accurate infection treatment.
  •  Avoids resistance to antibiotics.
  •  Diagnosis test reduction.
  •  Cost reduction of hospital stay.

 CLART® PneumoVir TECHNICAL FEATURES:

 SAMPLE TYPE

For this test nasopharyngeal washes are acceptable specimens.

 FULL INFORMATION

Simultaneous detection of 17 types and subtypes of respiratory viruses: Influenza A, Influenza B, Influenza C, Parainfluenza 1, Parainfluenza 2, Parainfluenza 3, Parainfluenza 4a, Parainfluenza 4b, RSV a, RSV B, Rhinovirus, Adenovirus, Echovirus, Bocavirus, Coronavirus, Metapneumovirus A and Metapneumovirus B.

 HIGH QUALITY RESULTS

The array 120 spots make possible the specific identification of multiple viral probes and assure the sensitivity and the specificity of each test.

 

 RELIABILITY

An internal control is included, which assures the extraction and amplification steps are processed successfully and avoids the false negative results.

 AUTOMATIC RESULTS

In order to avoid subjective interpretations, the results are processed by a microarray reader through an specific software. It allows automatic detection and interpretation of the results, getting a full and specific diagnosis of each analysis in a report.

 

 Patent Pending.

CLART® PneumoVir Kit, accomplish with all the normatives described in EU 98/79/CE for IVD.

 

descargar CLART® PneumoVir Manual [ 2,058.75 KB]
descargar CLART® PneumoVir Flyer [ 2,579.53 KB]
descargar CLART PneumoVir Portugues [ 2,034.85 KB]
Copyright Info Legal Boletín Digital Desarrollo:artempus